Lower HIV-2 plasma viral loads may explain differences between the naturalhistories of HIV-1 and HIV-2 infections

To explain the low transmissibility and pathogenicity of HIV-2 infection's plasma viral lends in both HIV-1- and HIV-2-infected persons were compared by using the polymerase chain reaction (PCR)-based Amp-RT assay to measure levels of reverse transcriptase (RT) activity. The study comprised a total of 155 HIV-infected-people including 58 who were infected with HIV-2 with C D4(+) cell counts <500 x 10(6)/L (n = 15), CD4(+) cell counts >500 x 10(6)/ L (n = 26), or with tuberculosis (TB; n = 17), and 97 HIV-1-infected people with CD4(+) cell counts <500 x 10(6)/L (n = 32), CD4(+) cell counts <500 x 10(6)/L (n = 25), or TB (n = 40). Among persons with CD4(+) cell counts <5 00 x 10(6)/L, 11 (73.3%) of 15 HIV-2-infected persons had detectable plasma RT activity compared with 25 (78.1%) of 32 HIV-1-infected persons (p = .72 5), However, the median HIV-2 plasma RT activity in this group was signific antly lower (2561 x 10(-10) U/ml; p = .036; detectable range, 1712-644,868 x 10(-10) U/ml) than the RT activity of HIV-1-infected persons with similar CD4(+) cell counts (13,241 x 10(-10) U/ml; detectable range, 8482-1,478,88 0 x 10(-10) U/ml). Among TB patients, 10 (58.8%) of 17 HIV-2-infected perso ns had detectable plasma RT activity compared with 30 (75%) of 40 HIV-1-inf ected persons (p = .342). In contrast, among patients with CD4(+) cell coun ts >500 x 10(6)/L, none of 26 HIV-2-infected persons had detectable RT acti vity compared with 13 (52%) of 25 HIV-1-infected persons (p < .001). Our da ta suggest that unlike HIV-1 infection, HIV-2 infections with CD4(+) cell c ounts >500 x 10(6)/L are associated with a low level of viral replication, which may explain the longer clinical latency and lower transmissibility se en in HIV-2 infection.